Annual Financials for Todos Medical Ltd.
Operating Activities
Fiscal year is January-December. All values USD millions. |
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
Net Income before Extraordinaries |
(2.68M) | (457,541) | (11.81M) | (29.77M) | (43.31M) | |
Net Income Growth |
- | 82.90% | -2,482.18% | -152.00% | -45.48% | |
Depreciation, Depletion & Amortization |
24,083 | 25,502 | 29,643 | 96,000 | 763,000 | |
Depreciation and Depletion |
24,083 | 25,502 | 29,643 | 96,000 | 763,000 | |
Amortization of Intangible Assets |
- | - | - | - | - | |
Deferred Taxes & Investment Tax Credit |
- | - | - | - | - | |
Deferred Taxes |
- | - | - | - | - | |
Investment Tax Credit |
- | - | - | - | - | |
Other Funds |
1.69M | (875,827) | 9.53M | 25.39M | 32.54M | |
Funds from Operations |
(965,144) | (1.31M) | (2.25M) | (4.29M) | (10.01M) | |
Extraordinaries |
- | - | - | - | - | |
Changes in Working Capital |
60,734 | 251,570 | 975,850 | 1.73M | (1.19M) | |
Receivables |
- | - | - | (537,000) | (2.08M) | |
Accounts Payable |
(21,874) | 163,174 | 363,469 | 1.41M | (100,000) | |
Other Assets/Liabilities |
82,608 | 88,396 | 612,381 | 1.24M | 2.05M | |
Net Operating Cash Flow |
(904,410) | (1.06M) | (1.28M) | (2.56M) | (11.2M) | |
Net Operating Cash Flow Growth |
- | -16.79% | -20.82% | -100.43% | -337.92% | |
Net Operating Cash Flow / Sales |
- | - | - | -49.13% | -91.59% | |
Investing Activities
|
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
Capital Expenditures |
(3,596) | (15,370) | (1,073) | (2.48M) | (1.1M) | |
Capital Expenditures (Fixed Assets) |
(3,596) | (15,370) | (1,073) | (2.03M) | (1.1M) | |
Capital Expenditures (Other Assets) |
- | - | - | (450,000) | - | |
Capital Expenditures Growth |
- | -327.42% | 93.02% | -231,027.68% | 55.77% | |
Capital Expenditures / Sales |
- | - | - | -47.63% | -8.97% | |
Net Assets from Acquisitions |
- | - | - | - | (2.43M) | |
Sale of Fixed Assets & Businesses |
- | - | - | - | - | |
Purchase/Sale of Investments |
(10,099) | - | (447,621) | (1.14M) | (1.18M) | |
Purchase of Investments |
(10,099) | - | (447,621) | (1.14M) | (1.18M) | |
Sale/Maturity of Investments |
- | - | - | - | - | |
Other Uses |
- | - | - | - | - | |
Other Sources |
- | - | - | - | - | |
Net Investing Cash Flow |
(13,695) | (15,370) | (448,694) | (3.62M) | (4.71M) | |
Net Investing Cash Flow Growth |
- | -12.23% | -2,819.28% | -705.89% | -30.14% | |
Net Investing Cash Flow / Sales |
- | - | - | -69.44% | -38.48% | |
Financing Activities
|
2017 | 2018 | 2019 | 2020 | 2021 |
5-year trend |
Cash Dividends Paid - Total |
- | - | - | - | - | |
Common Dividends |
- | - | - | - | - | |
Preferred Dividends |
- | - | - | - | - | |
Change in Capital Stock |
1.16M | 424,258 | 295,000 | 2.37M | 255,000 | |
Repurchase of Common & Preferred Stk. |
- | - | - | - | - | |
Sale of Common & Preferred Stock |
1.16M | 424,258 | 295,000 | 2.37M | 255,000 | |
Proceeds from Stock Options |
562,604 | 80,345 | 295,000 | 2.37M | 255,000 | |
Other Proceeds from Sale of Stock |
599,626 | 343,913 | - | - | - | |
Issuance/Reduction of Debt, Net |
- | 27,000 | 1.37M | 4.72M | 14.91M | |
Change in Current Debt |
- | 27,000 | - | 300,000 | (1.09M) | |
Change in Long-Term Debt |
- | - | 1.37M | 4.42M | 16M | |
Issuance of Long-Term Debt |
- | - | 1.37M | 4.42M | 16M | |
Reduction in Long-Term Debt |
- | - | - | - | - | |
Other Funds |
- | - | - | - | - | |
Other Uses |
- | - | - | - | - | |
Other Sources |
- | - | - | - | - | |
Net Financing Cash Flow |
1.16M | 451,258 | 1.67M | 7.09M | 15.16M | |
Net Financing Cash Flow Growth |
- | -61.17% | 269.96% | 324.81% | 113.79% | |
Net Financing Cash Flow / Sales |
- | - | - | 136.20% | 123.97% | |
Exchange Rate Effect |
- | - | - | - | - | |
Miscellaneous Funds |
- | - | - | - | - | |
Net Change in Cash |
244,125 | (620,408) | (55,463) | 918,000 | (746,000) | |
Free Cash Flow |
(908,010) | (1.07M) | (1.28M) | (4.59M) | (12.3M) | |
Free Cash Flow Growth |
- | -18.02% | -19.19% | -259.19% | -168.07% | |
Free Cash Flow Yield |
- | - | - | - | -30.96% | NA |